Purchase Order 75N93021P01485
Award Date 9/27/21
Potential Completion Date 2/8/27
Potential Value $1.4M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for custom peptide synthesis on June 16, 2018, with a ceiling value of $16,246.79. Work is performed in Piscataway, New Jersey. The order carries firm fixed pricing and no small business set-aside. Ultimate completion is scheduled for June 15, 2019.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for custom peptide synthesis on September 13, 2018, with a ceiling value of $17,503.39.</p> <p>Work is performed in Piscataway, New Jersey. The order is firm fixed price with an ultimate completion date of October 31, 2018. No set-aside category applies.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. valued at $30,200.12 on September 11, 2017. Performance is at Genscript's facility in Piscataway, New Jersey. The order was firm fixed price with no small business set-aside. Ultimate completion was September 18, 2017.</p>
- <p>Genscript USA Inc. has been awarded a $11,395.74 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide purified peptide services. The one-year contract, which runs from July 2023 through July 2024, will support NIH/NIAID's research efforts. No subcontractors or set aside designations were identified. Genscript will perform the peptide purification work at its facility in Piscataway, New Jersey.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for $249,943.63 on September 16, 2019. The order covers DNA synthesis, plasmid, and protein production services. Work is performed in Piscataway, New Jersey. The purchase order is firm fixed price with an ultimate completion date of January 31, 2020. The order originated from a pre-solicitation opportunity posted September 11, 2019.</p>
- This contract was awarded by the National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $5,353.40 firm fixed price delivery order is for peptide services and was completed on September 9, 2015. The contract has no set-aside designation. Genscript is a supplier of various products and services to federal agencies, including gene synthesis, gene editing, custom protein and antibody production, and...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. valued at $1,147,346.00 on September 26, 2019, for customized biologicals under firm fixed pricing. Performance is located in Piscataway, New Jersey. The order has no small business set-aside and carried an ultimate completion date of September 25, 2020. The originating pre-solicitation was posted September 3, 2019, with a due date of September 6, 2019.</p>
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in New Jersey. The $19,530.58 contract requires Genscript to provide 187 custom peptide conjugations at $104.00 each, with an ultimate completion date of October 14, 2010. The contract does not have a set-aside designation. Genscript is a well-established supplier of molecular...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for sequencing and gene synthesis services for 100 samples on March 17, 2022, with a ceiling value of $15,389.60. Work is performed in Piscataway, New Jersey. The order is firm fixed price with no set-aside designation and an ultimate completion date of March 16, 2023.</p>
- This firm fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company, has a potential value of $8,163.25. The award is for peptide services and does not have a set-aside designation. Genscript is a provider of gene synthesis, gene editing, protein production, and other molecular biology services to various federal agencies, including the NIH, CDC, FDA, and...